Eplerenone (inspra) manufacturing plant cost?

I don’t have a single universally published figure for the manufacturing plant cost of Inspra (eplerenone), because plant-capex is usually disclosed only in company filings, investment cases, or government/permit documents—and those figures are often not specific to one product brand.

That said, I can help you find the right number if you clarify what you mean:

1. Which plant/location? (country/city or company/owner)
2. Timeframe? (when it was built/expanded)
3. Do you mean “unit manufacturing plant for eplerenone API”, “finished-dose tablets”, or both?
4. Do you need the original capex estimate or an updated/total cost?

What I can do next

• If you tell me the manufacturer/company or site you’re referring to, I can search for likely sources (e.g., SEC filings, annual reports, FDA/EMA inspection-related disclosures, local investment announcements, CapEx/production expansion press releases).
• If you don’t know the site, I can instead give you a typical industry estimate range for building a small-to-mid pharmaceutical solid oral dosage facility vs an API facility—but that would be a proxy, not the exact Inspra/Eplerenone plant cost.

Reply with any details you have (company/site/country/year), and I’ll narrow it down.